Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. ASP8273

   Astellas Pharma Inc

   Non-small Cell Lung Cancer

   phase 2 · small molecule · terminated

   1 trial →

2. ASPIRE

   The George Institute

   Patients with resectable hepatocellular carcinoma (amenable R0 resection) at high risk of recurrence.

   phase 2 · small molecule · active

   1 trial →

3. ASTX727

   Taiho Pharma Netherlands B.V.

   Acute myeloid lymphoma (AML), myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML) or solid tumors

   phase 2 · small molecule · active

   1 trial →

4. ASTX727-07

   Taiho Pharma Netherlands B.V.

   Acute Myeloid Leukemia (AML)

   phase 2 · small molecule · active

   1 trial →

5. AT148009

   ALX ONCOLOGY HOLDINGS INC

   Breast Cancer

   phase 2 · small molecule · active

   1 trial →

6. ATEZOLIZUMAB

   The George Institute

   Patients with metastatic tumours (colorectal, non-small cell lung, renal and sarcoma)

   phase 2 · small molecule · active

   1 trial →

7. ATRN-119

   Aprea Therapeutics

   Advanced Solid Tumor

   phase 2 · small molecule · active

   1 trial →

8. ATRN-119

   Aprea Therapeutics

   HPV Positive Oropharyngeal Squamous Cell Carcinoma

   phase 2 · small molecule · active

   1 trial →

9. AU-011

   Aura Biosciences

   Eye Cancer

   phase 2 · small molecule · active

   1 trial →

10. AU-011

    Aura Biosciences

    Uveal Melanoma

    phase 2 · small molecule · completed

    1 trial →

11. AUR103 Calcium

    Disc Medicine

    HER 2 Positive Gastric Cancer

    phase 2 · small molecule · terminated

    1 trial →

12. AUTO1

    Autolus GmbH

    Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia

    phase 2 · mab · active

    2 trials →

13. AUTO3

    Autolus GmbH

    Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

    phase 2 · mab · terminated

    1 trial →

14. AUTO3 (CD19/22 CAR T cells

    Autolus GmbH

    B Acute Lymphoblastic Leukemia

    phase 2 · mab · completed

    1 trial →

15. AUTO4

    Autolus GmbH

    T Cell Non-Hodgkin Lymphoma

    phase 2 · mab · terminated

    1 trial →

16. AUY922

    Novartis Pharmaceuticals

    Advanced HER2-positive Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

17. AUY922

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastrointestinal Stromal Tumor

    phase 2 · small molecule · active

    1 trial →

18. AVELUMAB, Erbitux 5 mg/mL solution for infusion

    Fondazione Telethon ETS

    recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

    phase 2 · small molecule · active

    1 trial →

19. AVN944

    Vertex Pharmaceuticals (Australia) Pty.

    Pancreatic Cancer

    phase 2 · small molecule · terminated

    1 trial →

20. AZD0486, AZD0486

    AstraZeneca AB

    Relapsed or Refractory Non-Hodgkin Lymphoma

    phase 2 · small molecule · active

    1 trial →

21. AZD2014

    Samsung Bioepis NL B.V.

    Cancer of Stomach

    phase 2 · small molecule · terminated

    1 trial →

22. AZD2265 (FPI-2265)

    AstraZeneca

    Metastatic Prostate Cancer

    phase 2 · small molecule · active

    1 trial →

23. AZD2281

    AstraZeneca

    Ovarian Neoplasms

    phase 2 · small molecule · completed

    1 trial →

24. AZD4360

    AstraZeneca AB

    Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

25. AZD4512

    AstraZeneca AB

    B-cell acute lymphoblastic leukemia (B-ALL)

    phase 2 · small molecule · active

    1 trial →

26. AZD4512

    AstraZeneca AB

    Non-Hodgkin lymphoma (NHL)

    phase 2 · small molecule · active

    1 trial →

27. AZD5069

    United Therapeutics Europe Ltd

    Metastatic Castration Resistant Prostate Cancer

    phase 2 · small molecule · terminated

    1 trial →

28. AZD5363

    United Therapeutics Europe Ltd

    Adenocarcinoma of the Prostate

    phase 2 · small molecule · active

    1 trial →

29. AZD5363

    Cardiff Oncology

    Estrogen Receptor Positive Breast Cancer

    phase 2 · small molecule · active

    1 trial →

30. AZD5363 when combined with weekly paclitaxel.

    AstraZeneca

    Advanced or Metastatic Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

31. AZD6738

    United Therapeutics Europe Ltd

    Breast Neoplasm

    phase 2 · small molecule · active

    1 trial →

32. AZD6738, Ceralasertib

    AstraZeneca AB

    Advanced Cancer Whose Tumours Contain Molecular Alterations

    phase 2 · small molecule · active

    1 trial →

33. AZD7789

    AstraZeneca AB

    Advanced or metastatic gastric and gastro-esophageal junction (GEJ) adenocarcinoma, Advanced or Metastatic Non-small Cell Lung Carcinoma, Advanced or Metastatic Solid Tumors

    phase 2 · small molecule · active

    1 trial →

34. AZD8931

    AstraZeneca

    Neoplasms

    phase 2 · small molecule · terminated

    1 trial →

35. AZD8931

    United Therapeutics Europe Ltd

    Metastatic Colorectal Cancer

    phase 2 · small molecule · completed

    1 trial →

36. AZD9291

    Samsung Bioepis NL B.V.

    Non-Small Cell Lung Cancer With EGFR T790M Mutation

    phase 2 · small molecule · active

    1 trial →

37. AZD9291

    Hospital Authority, Hong Kong

    Carcinoma, Non-Small-Cell Lung

    phase 2 · small molecule · active

    1 trial →

38. AZD9750, Saruparib

    AstraZeneca AB

    Metastatic Prostate Cancer

    phase 2 · small molecule · active

    1 trial →

39. AZD9793

    AstraZeneca AB

    Hepatocellular Carcinoma

    phase 2 · small molecule · active

    1 trial →

40. Abemaciclib

    Teva Pharma GmbH

    Triple Negative Breast Neoplasms

    phase 2 · small molecule · active

    1 trial →

41. Abemaciclib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Metastases From Colorectal Cancer (mCRC)

    phase 2 · small molecule · active

    1 trial →

42. Abexinostat

    Xynomic Pharmaceuticals

    Non Hodgkin Lymphoma

    phase 2 · small molecule · active

    1 trial →

43. Abiraterone Acetate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prostate Cancer

    phase 2 · small molecule · active

    1 trial →

44. Abiraterone Acetate

    United Therapeutics Europe Ltd

    Metastatic Castration Resistant Prostate Cancer

    phase 2 · small molecule · terminated

    1 trial →

45. Abiraterone acetate

    United Therapeutics Europe Ltd

    Prostate Cancer (Adenocarcinoma)

    phase 2 · small molecule · active

    1 trial →

46. Abraxane

    Duke University

    Metastatic Breast Cancer

    phase 2 · small molecule · terminated

    1 trial →

47. Absorbable and moldable skull base support plate

    The First People's Hospital of Lianyungang

    Sellar Tumor

    phase 2 · other · active

    1 trial →

48. Acalabrutinib

    United Therapeutics Europe Ltd

    Mantle Cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

Frequently asked questions